首页> 外文OA文献 >CD44 enhances invasion of basal-like breast cancer cells by upregulating serine protease and collagen-degrading enzymatic expression and activity
【2h】

CD44 enhances invasion of basal-like breast cancer cells by upregulating serine protease and collagen-degrading enzymatic expression and activity

机译:CD44通过上调丝氨酸蛋白酶和胶原降解酶促表达和活性来增强基底样乳腺癌细胞的侵袭

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Introduction: Basal-like breast cancers (BL-BCa) have the worst prognosis of all subgroups of this disease. Hyaluronan (HA) and the HA receptor CD44 have a long-standing association with cell invasion and metastasis of breast cancer. The purpose of this study was to establish the relation of CD44 to BL-BCa and to characterize how HA/CD44 signaling promotes a protease-dependent invasion of breast cancer (BrCa) cells. Methods: CD44 expression was determined with immunohistochemistry (IHC) analysis of a breast cancer tissue microarray (TMA). In vitro experiments were performed on a panel of invasive BL-BCa cell lines, by using quantitative polymerase chain reaction (PCR), immunoblotting, protease activity assays, and invasion assays to characterize the basis of HA-induced, CD44-mediated invasion. Results: Expression of the hyaluronan (HA) receptor CD44 associated with the basal-like subgroup in a cohort of 141 breast tumor specimens (P = 0.018). Highly invasive cells of the representative BL-BCa cell line, MDA-MB-231 (MDA-MB-231Hi) exhibited increased invasion through a basement membrane matrix (Matrigel) and collagen. In further experiments, HA-induced promotion of CD44 signaling potentiated expression of urokinase plasminogen activator (uPA) and its receptor uPAR, and underpinned an increased cell-associated activity of this serine protease in MDA-MB-231Hi and a further BL-BCa cell line, Hs578T cells. Knockdown of CD44 attenuated both basal and HA-stimulated uPA and uPAR gene expression and uPA activity. Inhibition of uPA activity by using (a) a gene-targeted RNAi or (b) a small-molecule inhibitor of uPA attenuated HA-induced invasion of MDA-MB-231Hi cells through Matrigel. HA/CD44 signaling also was shown to increase invasion of MDA-MB-231 cells through collagen and to potentiate the collagen-degrading activity of MDA-MB-231Hi cells. CD44 signaling was subsequently shown to upregulate expression of two potent collagen-degrading enzymes, the cysteine protease cathepsin K and the matrix metalloprotease MT1-MMP. RNAi- or shRNA-mediated depletion of CD44 in MDA-MB-231Hi cells decreased basal and HA-induced cathepsin K and MT1-MMP expression, reduced the collagen-degrading activity of the cell, and attenuated cell invasion through collagen. Pharmacologic inhibition of cathepsin K or RNAi-mediated depletion of MT1-MMP also attenuated MDA-MB-231Hi cell invasion through collagen. Conclusion: HA-induced CD44 signaling increases a diverse spectrum of protease activity to facilitate the invasion associated with BL-BCa cells, providing new insights into the molecular basis of CD44-promoted invasion.
机译:简介:基底样乳腺癌(BL-BCa)在该疾病所有亚组中的预后最差。透明质酸(HA)和HA受体CD44与乳腺癌的细胞浸润和转移有着长期的联系。这项研究的目的是建立CD44与BL-BCa的关系,并表征HA / CD44信号传导如何促进蛋白酶依赖性乳腺癌(BrCa)细胞的侵袭。方法:通过免疫组织化学(IHC)分析乳腺癌组织微阵列(TMA)测定CD44表达。通过使用定量聚合酶链反应(PCR),免疫印迹,蛋白酶活性测定和侵袭测定来表征HA诱导的CD44介导的侵袭的基础,在一组侵袭性BL-BCa细胞系上进行了体外实验。结果:透明质酸(HA)受体CD44与基底样亚组相关的表达在141个乳腺肿瘤标本队列中的表达(P = 0.018)。代表性BL-BCa细胞系MDA-MB-231(MDA-MB-231Hi)的高侵袭性细胞通过基底膜基质(Matrigel)和胶原蛋白的侵袭增加。在进一步的实验中,HA诱导的CD44信号传导的增强增强了尿激酶纤溶酶原激活物(uPA)及其受体uPAR的表达,并支持了这种丝氨酸蛋白酶在MDA-MB-231Hi和其他BL-BCa细胞中与细胞相关的活性增强系,Hs578T细胞。击倒CD44减弱了基础和HA刺激的uPA和uPAR基因表达以及uPA活性。通过使用(a)基因靶向的RNAi或(b)uPA的小分子抑制剂来抑制uPA活性,可减弱HA诱导的通过Matrigel诱导的MDA-MB-231Hi细胞入侵。还显示了HA / CD44信号转导通过胶原蛋白增加了MDA-MB-231细胞的侵袭并增强了MDA-MB-231Hi细胞的胶原蛋白降解活性。随后显示CD44信号转导上调两种有效的胶原降解酶,半胱氨酸蛋白酶组织蛋白酶K和基质金属蛋白酶MT1-MMP的表达。 MDA-MB-231Hi细胞中RNAi或shRNA介导的CD44耗竭降低了基础和HA诱导的组织蛋白酶K和MT1-MMP表达,降低了细胞的胶原蛋白降解活性,并减弱了细胞通过胶原蛋白的侵袭。组织蛋白酶K的药理学抑制或RNAi介导的MT1-MMP耗竭也减弱了MDA-MB-231Hi细胞通过胶原的入侵。结论:HA诱导的CD44信号传导增加了蛋白酶活性的多种谱,以促进与BL-BCa细胞相关的侵袭,为CD44促进的侵袭的分子基础提供了新的见解。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号